Skip to content

Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence

Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05530993
Enrollment
20
Registered
2022-09-07
Start date
2023-02-01
Completion date
2023-06-20
Last updated
2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PrEP Adherence Experiences, PrEP Adherence Perspectives, PrEP Uptake Experiences, PrEP Uptake Perspectives

Brief summary

The aim is to conduct two virtual focus groups (10 participants in each group) with 20 pre-exposure prophylaxis (PrEP)-eligible Black women in Houston and Austin, TX. Participants will be assigned to focus groups with other women based on their position about PrEP uptake (considered use versus not considered use). Focus group questions will build on an ecologic model framework to inquire about participant's intrapersonal, interpersonal, and community-level factors that influence access to and use of HIV prevention services. This strategy aims to examine potential barriers to PrEP uptake among PrEP-eligible women in two Texas' hotspots.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* assigned female sex at birth * identify as Black or African American * 18 years of age or older * have had condomless sex with a cisgender man within the past 12 months * fluent in English or Spanish * have a phone or internet access * not currently on PrEP and have never taken PrEP

Exclusion criteria

* choose not to identify as Black or African American * unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent) * have psychological distress that would prohibit them from participating in the study * unable or unwilling to meet study requirements * ineligible for HIV prevention services \[i.e., Human Immunodeficiency Virus (HIV) Positive\] * received a prescription for PrEP within 12 months * has a history of PrEP uptake or is currently on PrEP

Design outcomes

Primary

MeasureTime frameDescription
Facilitators to readiness to adopt PrEPduring the focus groupA focus group will be used to identify facilitators to readiness to adopt PrEP (a focus group is a group interview among the study participants with the purpose of collecting information about a topic, in this case facilitators to readiness to adopt PrEP). During the focus group, focus group participants will be asked to indicate facilitators to readiness to adopt PrEP, and these facilitators to readiness will be recorded at the time of the focus group. These facilitators to readiness identified during the focus group will be reported categorically.
Barriers to readiness to adopt PrEPduring the focus groupA focus group will be used to identify barriers to readiness to adopt PrEP (a focus group is a group interview among the study participants with the purpose of collecting information about a topic, in this case barriers to readiness to adopt PrEP). During the focus group, focus group participants will be asked to indicate barriers to readiness to adopt PrEP, and these barriers to readiness will be recorded at the time of the focus group. These barriers to readiness identified during the focus group will be reported categorically.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026